Here are four quick facts:
1. Brokers have set a one-year consensus target price of $23.33 for the company.
2. EndoChoice has a one-year low of $14.26 and a one-year high of $19.69.
3. The stock’s 50 day moving average is $16.13 and its 200-day moving average is $16.25.
4. The firm’s market cap is $414.19 million.
More articles on GI/endoscopy:
CMS to uphold Medicare reimbursement for Cologuard
To stay or go? When GI physicians consider changing practice settings
Dr. Ayan Rage joins Essentia Health
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
